Figure 1.
Figure 1. Cumulative incidence of acute GVHD after administration of MAPC on Day 2 after conventional allogeneic HSCT in setting of tacrolimus & methotrexate GVHD prophylaxis.

Cumulative incidence of acute GVHD after administration of MAPC on Day 2 after conventional allogeneic HSCT in setting of tacrolimus & methotrexate GVHD prophylaxis.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal